Abbott downgraded to Market Perform from Outperform at Leerink Leerink downgraded Abbott based on full valuation ahead of the split expected in January 2013. Price target range is $65-$70.
News For ABT From The Last 14 Days
Check below for free stories on ABT the last two weeks.